Search results
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
US News & World Report· 3 days agoAn experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests. The drug under development, survodutide, helped up to 83% of ...
Novel Intelligent Liver Function Test Platform Improves Liver Disease Diagnosis
MedPage Today· 7 days agoAn intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary...
These Are The 5 Biggest Early Warning Signs Of Liver Damage
BuzzFeed via Yahoo News· 4 days agoYour liver, which is the largest internal organ in your body, is responsible for a lot. It regulates...
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Motley Fool via Yahoo Finance· 3 days agoViking Therapeutics (NASDAQ: VKTX) and Madrigal Pharmaceuticals (NASDAQ: MDGL) are highly prominent...
Ipsen drug for rare liver disease approved by FDA
BioPharma Dive via Yahoo Finance· 2 days agoThe medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...
iLFT Platform Helps Detect Chronic Liver Disease
Medscape· 7 days agoThe intelligent Liver Function Testing (iLFT) platform automatically determines which patients should get follow-on testing and, if needed, subsequent...
Utahns implicated in a coup attempt in Congo go on trial before a military court
KUTV Salt Lake City· 6 days agoThree Americans accused of being involved in last month's coup attempt in Congo appeared in a...
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 2 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver disease, Iqirvo, the companies said ...
Edible Carbon Beads Can Reduce Cirrhosis Liver Disease By Restoring Gut Microbiome
GoodNewsNetwork· 4 days agoInnovative carbon beads, invented by researchers at University College London, reduce bad bacteria...